Početna › Ulcerativni kolitis › Texas › Lubbock
Kliničke studije za Ulcerativni kolitis u gradu Lubbock, TX
9 studija za Ulcerativni kolitis traži sudionike na lokacijama u gradu Lubbock i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
U tijeku regrutacijaFaza 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
U tijeku regrutacijaFaza 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
U tijeku regrutacijaFaza 4
- West Texas Research Institute, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
- Xencor Investigative Site, Lubbock
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 2
- Site US-015, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
U tijeku regrutacijaFaza 2
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
U tijeku regrutacijaFaza 3
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
U tijeku regrutacijaFaza 2
- Mirador Therapeutics Selected Site, Lubbock
Studije za Ulcerativni kolitis u drugim gradovima
- New York City, NY23 studija
- Orlando, FL22 studija
- Miami, FL21 studija
- Houston, TX17 studija
- San Antonio, TX16 studija
- Chicago, IL15 studija
- Tacoma, WA15 studija
- San Diego, CA15 studija
- Tyler, TX14 studija
- Colorado Springs, CO14 studija
- Los Angeles, CA13 studija
- St. Louis, MO13 studija
Ostale studije u gradu Lubbock
- Crohnova bolest10 studija
- Rak dojke6 studija
- Nemikrocelularni karcinom pluća4 studija
- Psorijatični artritis3 studija
- Moždani udar3 studija
- Prekomjerna tjelesna masa3 studija
- Debljina3 studija
- Upalna bolest crijeva3 studija
- Burkittov limfom3 studija
- Multipli mijelom3 studija
Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.